Cardiometabolic Disorders News

BOSTON — Masked hypertension is an underappreciated phenomenon that confers extra risk for CVD and chronic kidney disease, and simple steps such as home BP monitoring and stepped-up medications can improve outcomes, according to a speaker.

BOSTON — Continuous glucose monitoring is a well-established therapy for type 2 diabetes on intensive and less intensive therapy, but education, training and infrastructure in the clinic are crucial to its success, according to a speaker.

BOSTON — In this Healio video exclusive, Juan P. Frias, MD, discusses his presentation on newer treatment options for type 2 diabetes at the Cardiometabolic Health Congress.

BOSTON — In this Healio video exclusive, a co-chair of the Cardiometabolic Health Congress discusses various highlights from the first 2.5 days of the meeting.

BOSTON — There is strong evidence for a casual association between lipoprotein(a) concentration and CV outcomes across ethnicities, and Lp(a) “should be measured at least once” in all adults to identify high CV risk, according to a speaker.

BOSTON — So-called pre-obesity, or a BMI between 25 and 30 kg/m2, is associated with all-cause and cause-specific mortality similar to overt obesity and treatment should begin early to reduce cardiometabolic risk, according to a speaker.

BOSTON — The concepts of precision diabetes medicine, including individualized therapy, carefully tracked progress and a team approach, can break down therapeutic inertia barriers and help patients achieve remission, according to a speaker.

The 2022 Cardiometabolic Health Congress will return in-person to Boston with the latest updates spanning all aspects of cardiometabolic health, including CVD, diabetes, kidney disease, lipid and lifestyle management and obesity.

Increasing daily step counts may reduce the risk for chronic diseases such as obesity, sleep apnea and major depressive disorder, a study published in Nature Medicine found.

The benefits of gender-affirming hormone therapy outweigh the risks for transgender women of all ages as well as those with comorbidities, according to a speaker at the 2022 North American Menopause Society annual meeting.